Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
 
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size

    Article Cited by others

ORIGINAL ARTICLE

Prognostic factors and long term results of neo adjuvant therapy followed by surgery in stage IIIA N2 non-small cell lung cancer patients

Li Jing, Dai Chun-Hua, Shi Shun-Bing, Chen Ping, Yu Li-Chao, Wu Jian-Rong

Year : 2009| Volume: 4| Issue : 4 | Page no: 201-207

   This article has been cited by
 
1 Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non–small cell lung cancer
Chi-Fu Jeffrey Yang,Brian C. Gulack,Lin Gu,Paul J. Speicher,Xiaofei Wang,David H. Harpole,Mark W. Onaitis,Thomas A. DæAmico,Mark F. Berry,Matthew G. Hartwig
The Journal of Thoracic and Cardiovascular Surgery. 2015; 150(6): 1484
[Pubmed]  [Google Scholar] [DOI]
2 Surgery for Stage IIIA Non–Small-cell Lung Cancer: Lack of Predictive and Prognostic Factors Identifying Any Subgroup of Patients Benefiting From It
Branislav Jeremic,Francesc Casas,Pavol Dubinsky,Antonio Gomez-Caamano,Nikola Cihoric,Greg Videtic
Clinical Lung Cancer. 2015;
[Pubmed]  [Google Scholar] [DOI]
3 Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N2 non-small cell lung cancer
Dong Yan,Ping Wei,Guangyu An,Wenming Chen
Journal of Cardiothoracic Surgery. 2013; 8(1): 149
[Pubmed]  [Google Scholar] [DOI]
4 Variability in the Treatment of Elderly Patients with Stage IIIA (N2) Non–Small-Cell Lung Cancer
Mark F. Berry,Mathias Worni,Ricardo Pietrobon,Thomas A. D’Amico,Igor Akushevich
Journal of Thoracic Oncology. 2013; 8(6): 744
[Pubmed]  [Google Scholar] [DOI]
5 Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N2 non-small cell lung cancer
Yan, D. and Wei, P. and An, G. and Chen, W.
Journal of Cardiothoracic Surgery. 2013; 8(1)
[Pubmed]  [Google Scholar]
6 Variability in the treatment of elderly patients with stage IIIA (N2) non-small-cell lung cancer
Berry, M.F. and Worni, M. and Pietrobon, R. and DæAmico, T.A. and Akushevich, I.
Journal of Thoracic Oncology. 2013; 8(6): 744-752
[Pubmed]  [Google Scholar]
7 Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer
Shah, A.A. and Berry, M.F. and Tzao, C. and Gandhi, M. and Worni, M. and Pietrobon, R. and DæAmico, T.A.
Annals of Thoracic Surgery. 2012; 93(6): 1807-1812
[Pubmed]  [Google Scholar]
8 Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer
Asad A. Shah,Mark F. Berry,Ching Tzao,Mihir Gandhi,Mathias Worni,Ricardo Pietrobon,Thomas A. DæAmico
The Annals of Thoracic Surgery. 2012; 93(6): 1807
[Pubmed]  [Google Scholar] [DOI]
9 Survival impact of node zone classification in resected pathological N2 non-small cell lung cancer
T. Baba, H. Uramoto, T. Kuwata, Y. Chikaishi, M. Nakagawa, T. So, T. Hanagiri, F. Tanaka
Interactive Cardiovascular and Thoracic Surgery. 2012;
[HTML Full text]  [Google Scholar] [DOI]
10 Superior vena cava syndrome in thoracic malignancies
Lepper, P.M., Ott, S.R., Hoppe, H., Schumann, C., Stammberger, U., Bugalho, A., Frese, S., (...), Hamacher, J.
Respiratory Care. 2011; 56(5): 653-666
[Pubmed]  [Google Scholar]

 

Read this article